NEW YORK, June 14, 2012 /PRNewswire/ — The second installment of the successful EBM Debates series, launched in March 2012, will go live tomorrow, Friday, June 15, beginning at 12:30 PM Pacific, 2:30 PM Central, and 3:30 PM Eastern. This debate will cover a topic of increasing importance in the field of Alzheimer’s disease research: “Why are there so many late-stage drug development failures in Alzheimer’s disease?” Powered 4 Significance LLC, a Blue Ocean Pharma company, is hosting the virtual event that will have faculty joining from two locations Houston and Las Vegas Continue reading →